IL1B and idiopathic pulmonary fibrosis: This benefit in the lung function is supported indirectly by the measurements of IL-1β and of IL-1ra (receptor antagonist) in the epithelial lining fluid of 54 patients with idiopathic pulmonary fibrosis (IPF).